Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · IEX Real-Time Price · USD
12.78
+0.39 (3.13%)
At close: Jul 19, 2024, 4:00 PM
12.77
-0.01 (-0.06%)
Pre-market: Jul 22, 2024, 6:59 AM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $13.21 million as of July 22, 2024. Its market cap has increased by 181.15% in one year.
Market Cap
13.21M
Enterprise Value
-96.97M
1-Year Change
181.15%
Ranking
Category
Stock Price
$12.78
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has decreased from $34.50M to $13.21M, a decrease of -61.70%. That is a compound annual growth rate of -10.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 13.20M | 80.82% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kazia Therapeutics | 13.63M |
| Universe Pharmaceuticals INC | 13.53M |
| Kiora Pharmaceuticals | 13.37M |
| Psychemedics | 13.35M |
| QT Imaging Holdings | 13.29M |
| NeuroSense Therapeutics | 13.20M |
| Addex Therapeutics | 13.17M |
| GeoVax Labs | 12.98M |